It was developed in the 1990s by researchers at Monash University in Melbourne, Australia, with one goal: isolate the fat-burning portion of growth hormone and deliver those effects without the risks that come with full hGH administration
The thousands of anecdotal human reports suggest similar effects to animal studies, but formal human clinical trials remain lacking
Several factors support the theoretical viability of oral BPC-157, though human outcomes remain unproven: Gastric Stability: BPC-157 was originally studied for gastric protection in animal models, meaning the compound was administered directly into the stomach in research settings
BPC-157 The Healing Accelerator Known for its remarkable healing potential, BPC-157 supports both soft tissue and bone repair
The recommended dosage for B12 injections in adults is generally 100 mcg (0.1 mL) daily for 6 or 7 days, followed by a maintenance dose of 1,000 mcg once a month